Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HLA-A*02010102L: a laborious assignment.

P Perrier1, A Dormoy, C Andre-Botte

  • 1Laboratoire d'histocompatibilité, Vandoeuvre-les-Nancy, France. p.perrier@chu-nancy.fr

Tissue Antigens
|November 10, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unraveling the functional attributes of the language connectome: crucial subnetworks, flexibility and variability.

NeuroImage·2022
Same author

In situ delivery of allogeneic natural killer cell (NK) combined with Cetuximab in liver metastases of gastrointestinal carcinoma: A phase I clinical trial.

Oncoimmunology·2018
Same author

Impact of KIR/HLA genetic combinations on double umbilical cord blood transplantation outcomes. Results of a French multicentric retrospective study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC) and the Société Francophone d'Histocompatibilité et d'Immunogénétique (SFHI).

Bone marrow transplantation·2016
Same author

Risk factors and outcome of graft failure after HLA matched and mismatched unrelated donor hematopoietic stem cell transplantation: a study on behalf of SFGM-TC and SFHI.

Bone marrow transplantation·2016
Same author

Unusual association of myasthenia gravis and ulcerative colitis in a 14-year-old boy.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2014
Same author

Is there any impact of HLA-DPB1 disparity in 10/10 HLA-matched unrelated hematopoietic SCT? Results of a French multicentric retrospective study.

Bone marrow transplantation·2014
Same journal

Corrigendum.

Tissue antigens·2015
Same journal

Nomenclature for factors of the HLA system, update September 2015.

Tissue antigens·2015
Same journal

Nomenclature for factors of the HLA system, update August 2015.

Tissue antigens·2015
Same journal

Nomenclature for factors of the HLA system, update July 2015.

Tissue antigens·2015
Same journal

Four amino acid exchanges located in the alpha-2 domain specify the novel HLA-B*50:20 allele.

Tissue antigens·2015
Same journal

A novel HLA-A*02 variant, HLA-A*02:575, detected in a Taiwanese bone marrow hematopoietic stem cell donor.

Tissue antigens·2015
See all related articles

Researchers identified a novel HLA-A allele, A*02010102L, in a French family with reduced A2 antigen expression. A single point mutation in the enhancer B region was linked to this decreased expression, offering insights into HLA antigen variability.

Area of Science:

  • Immunogenetics
  • Human Leukocyte Antigen (HLA) complex
  • Molecular genetics

Background:

  • Reduced Human Leukocyte Antigen (HLA) A2 antigen expression was observed in a French family since the 1980s.
  • Previous serological tests indicated a deficiency in A2 antigen expression.

Purpose of the Study:

  • To identify the genetic basis of reduced A2 antigen expression in a French family.
  • To characterize the novel HLA-A allele responsible for the observed phenotype.

Main Methods:

  • Polymerase Chain Reaction Sequence-Specific Primer (PCR-SSP) typing was employed.
  • Comprehensive gene sequencing, including promoter, introns, and exons, was performed.
  • Serological testing was utilized to assess A2 antigen expression.

Related Experiment Videos

Main Results:

  • A novel allele, HLA-A*02010102L, was identified in three healthy individuals.
  • A single point mutation (T to C) at position -101 in the enhancer B region, compared to A*02010101, was found.
  • This mutation correlated with the reduced A2 antigen expression.

Conclusions:

  • The identified HLA-A*02010102L allele, characterized by a specific point mutation, is associated with reduced A2 antigen expression.
  • The study elucidates a novel genetic mechanism influencing HLA antigen expression levels.
  • The allele segregates with a distinct haplotype (Cw*12, B44, DR7, DQ2).